Lung cancer gene testing

Targeted therapy for lung cancer mainly targets the driver gene of lung cancer and uses targeted drugs for treatment. It mainly detects the gene of tumor tissue by puncturing the tumor tissue or drawing blood. I am glad to hear your words. I see a little problem and I feel that your description of this situation is the best here. Because in lung cancer, 60% to 70% of patients with adenocarcinoma will have gene mutations. If there are gene mutations, targeted therapy can be carried out.

How long can you live if lung cancer spreads to the lymph nodes?

If lung cancer has lymph node metastasis, especially supraclavicular lymph node metastasis, the condition is already in the middle and late stages of lung cancer, and surgery is meaningless. Treatment is mainly chemotherapy and targeted therapy. The survival period of middle and late stage lung cancer is about 1.5 years. If the patient is in good health and given active treatment, the survival period may be extended. Some advanced patients can survive for 2 to 3 years through targeted therapy. More than three months or less than one year. The question of how long can a patient with lung cancer lymph node metastasis live is relatively general.

What is early stage lung adenocarcinoma?

If lung adenocarcinoma patients can have it completely removed by surgery in the early stage, the chance of cure is relatively high. Adenocarcinoma is a pathological type of lung cancer. In the early stage, the tumor is normally small, without infiltration of surrounding tissues and organs and no distant metastasis. In this case, surgery can be performed to remove as much as possible. However, in the early stages of the disease, even invasive lung adenocarcinoma with poor pathological types has a very good overall prognosis. Early stage lung adenocarcinoma refers to lung tumors smaller than five centimeters.